Skip to search formSkip to main contentSkip to account menu

Cancer Progression

Known as: Cancer Disease Progression 
A pathologic process in which alterations at the molecular level result in a more aggressive cytologic and phenotypic profile and clinical course of… 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (1)

Disease Progression
Pathologic ProcessesTumor ImmunityTumor Progression

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expression
Previous studies have suggested that astrocyte-elevated gene-1 (AEG-1) contributes to the mechanisms of resistance to various… 
Review
2015
Review
2015
OPRM1 receptor as new biomarker to help the prediction of post mastectomy pain and recurrence in breast cancer.
Breast cancer is the most common type of cancer among women worldwide. Short-term postsurgical recovery is complicated by many… 
2013
2013
serous ovarian cancer signaling is associated with metastasis and poor survival in β A collagen-remodeling gene signature regulated by TGF
2012
2012
Preclinical Development miRNA-29 b Suppresses Prostate Cancer Metastasis by Regulating Epithelial – Mesenchymal Transition Signaling
Prostate cancer remains the second leading cause of cancer deaths among American men. Early diagnosis increases survival rate in… 
2011
2011
Pro-inflammatory type-1 and anti-inflammatory type-2 macrophages differentially modulate cell survival and invasion of human bladder carcinoma T24 cells.
2011
2011
Membrane type-1 matrix metalloproteinase (MT1-MMP) correlates with the expression and activation of matrix metalloproteinase-2 (MMP-2) in inflammatory breast cancer.
Inflammatory breast cancer (IBC) represents the most aggressive form of breast cancer, characterized by rapid progression… 
2011
2011
Development of a new stool biomarker ELISA for the early detection of colorectal cancer.
e14128 Background: An ELISA was developed using NPC-1C, a novel antibody that reacts with an antigen expressed specifically by… 
2009
2009
An iatrogenic confounding variable.
modest decline in prostate cancer mortality, but the absolute decline in the number of deaths averted is relatively modest when… 
2009
2009
Evaluation of the Distribution of Stem Cell Markers in Human Breast Cancer Reveals Correlation with Clinical Progression and Metastatic Disease in Ductal Carcinoma.
Background: Tumour stem cell theory suggests that a small percentage of cells in a tumour harbour intrinsic characteristics… 
Review
2008
Review
2008
Bevacizumab and oxaliplatin-based chemotherapy in metastatic colorectal cancer
In metastatic colorectal cancer disease progression correlates with serum VEGF levels. The importance of VEGF in tumor-induced… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)